ORG-201745
This is an old revision of this page, as edited by Vanished user 0x8cSXE0x6 (talk | contribs) at 13:10, 25 June 2018 (←Created page with '{{Drugbox | Verifiedfields = | Watchedfields = | verifiedrevid = | IUPAC_name = | image = | width = <!--Clinical data--> | tradename = | pregnancy_AU = <...'). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
| Clinical data | |
|---|---|
| Drug class | Progestin; Progestogen |
| Identifiers | |
| CAS Number | |
ORG-201745 is a progestin which was originated by Organon and was under development by Schering-Plough (which acquired Organon in 2007) for the treatment of "female genital diseases" and as a hormonal contraceptive for the prevention of pregnancy but was never marketed.[1]
References
External links
 | This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it. |
- Infobox drug articles without a structure image
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs missing an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- All stub articles